<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR47">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Panda</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Arul</surname>
    <given-names>MN</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Verma</surname>
    <given-names>SK</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Rubahn</surname>
    <given-names>H-G</given-names>
   </name>
   <name>
    <surname>Mishra</surname>
    <given-names>YK</given-names>
   </name>
   <name>
    <surname>Suar</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Ahuja</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <article-title>Structure-based drug designing and immunoinformatics approach for SARS-CoV-2</article-title>
  <source>Sci Adv</source>
  <year>2020</year>
  <volume>6</volume>
  <fpage>eabb8097</fpage>
  <pub-id pub-id-type="doi">10.1126/sciadv.abb8097</pub-id>
  <pub-id pub-id-type="pmid">32691011</pub-id>
 </element-citation>
</ref>
